Search research articles
Contact Us
Filters
Showing results (11-20 of 276) with videos related to
Page
of 28
Sort By:
Cellular & Molecular Immunology
|
December 16, 2021
CD28 costimulation promotes an antitumor CD8<sup>+</sup> T cell response in myeloid antigen-presenting cell niches
Jacques A Nunès, Daniel Olive
Frontiers in Oncology
|
September 17, 2021
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
Clemence Demerlé, Laurent Gorvel, Daniel Olive
Methods in Molecular Biology (Clifton, N.J.)
|
January 7, 2003
Generation of leukemic dendritic cells from patients with acute myeloid leukemia
Mohamad Mohty, Béatrice Gaugler, Daniel Olive
Frontiers in Immunology
|
December 28, 2020
3D Tumor Models and Their Use for the Testing of Immunotherapies
Nicolas Boucherit, Laurent Gorvel, Daniel Olive
Oncoimmunology
|
February 6, 2014
When breast cancer cells start to fend the educational process of NK cells off
Emilie Mamessier, Charlotte Bourgin, Daniel Olive
Expert Opinion on Biological Therapy
|
November 19, 2019
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
Florent Amatore, Laurent Gorvel, Daniel Olive
Medecine Sciences : M/S
|
January 7, 2020
[Next generation of anti-immune checkpoints antibodies]
Nathalie Bonnefoy, Daniel Olive, Bernard Vanhove
International Journal of Molecular Sciences
|
January 28, 2026
The Phylogenomic Approach Suggests That Butyrophilins Have Ligands Beyond Gamma-Delta Receptors
Ludovic Marenco, Daniel Olive, Pierre Pontarotti
Trends in Immunology
|
July 28, 2004
Plasmacytoid DCs and cancer: a new role for an enigmatic cell
Mohamad Mohty, Daniel Olive, Béatrice Gaugler
Expert Opinion on Therapeutic Targets
|
February 23, 2018
Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy
Florent Amatore, Laurent Gorvel, Daniel Olive
Page
of 28
Search research articles
Search
Showing results (11-20 of 276) with videos related to
Sort By:
Page
of 28
Cellular & Molecular Immunology
|
December 16, 2021
CD28 costimulation promotes an antitumor CD8<sup>+</sup> T cell response in myeloid antigen-presenting cell niches
Jacques A Nunès, Daniel Olive
Frontiers in Oncology
|
September 17, 2021
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
Clemence Demerlé, Laurent Gorvel, Daniel Olive
Methods in Molecular Biology (Clifton, N.J.)
|
January 7, 2003
Generation of leukemic dendritic cells from patients with acute myeloid leukemia
Mohamad Mohty, Béatrice Gaugler, Daniel Olive
Frontiers in Immunology
|
December 28, 2020
3D Tumor Models and Their Use for the Testing of Immunotherapies
Nicolas Boucherit, Laurent Gorvel, Daniel Olive
Oncoimmunology
|
February 6, 2014
When breast cancer cells start to fend the educational process of NK cells off
Emilie Mamessier, Charlotte Bourgin, Daniel Olive
Expert Opinion on Biological Therapy
|
November 19, 2019
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
Florent Amatore, Laurent Gorvel, Daniel Olive
Medecine Sciences : M/S
|
January 7, 2020
[Next generation of anti-immune checkpoints antibodies]
Nathalie Bonnefoy, Daniel Olive, Bernard Vanhove
International Journal of Molecular Sciences
|
January 28, 2026
The Phylogenomic Approach Suggests That Butyrophilins Have Ligands Beyond Gamma-Delta Receptors
Ludovic Marenco, Daniel Olive, Pierre Pontarotti
Trends in Immunology
|
July 28, 2004
Plasmacytoid DCs and cancer: a new role for an enigmatic cell
Mohamad Mohty, Daniel Olive, Béatrice Gaugler
Expert Opinion on Therapeutic Targets
|
February 23, 2018
Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy
Florent Amatore, Laurent Gorvel, Daniel Olive
Page
of 28